Insmed Inc’s recent filing unveils that its Chief Legal Officer Smith Michael Alexander unloaded Company’s shares for reported $0.14 million on Jun 05 ’25. In the deal valued at $73.50 per share,1,879 shares were sold. As a result of this transaction, Smith Michael Alexander now holds 67,718 shares worth roughly $4.99 million.
Then, Smith Michael Alexander bought 1,879 shares, generating $138,050 in total proceeds.
Before that, Smith Michael Alexander sold 1,448 shares. Insmed Inc shares valued at $103,532 were divested by the Chief Legal Officer at a price of $71.50 per share. As a result of the transaction, Smith Michael Alexander now holds 69,597 shares, worth roughly $5.12 million.
Jefferies initiated its Insmed Inc [INSM] rating to a Buy in a research note published on May 13, 2025; the price target was $105. A number of analysts have revised their coverage, including RBC Capital Mkts’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. Truist began covering INSM with “Buy” recommendation on April 23, 2024. Wolfe Research started covering the stock on February 15, 2024. It rated INSM as “an Outperform”.
Price Performance Review of INSM
On Friday, Insmed Inc [NASDAQ:INSM] saw its stock jump 1.21% to $73.62. Over the last five days, the stock has gained 5.58%. Insmed Inc shares have risen nearly 6.63% since the year began. Nevertheless, the stocks have risen 29.16% over the past one year. While a 52-week high of $84.91 was reached on 02/21/25, a 52-week low of $55.74 was recorded on 04/09/25. SMA at 50 days reached $69.91, while 200 days put it at $73.08.
Levels Of Support And Resistance For INSM Stock
The 24-hour chart illustrates a support level at 72.84, which if violated will result in even more drops to 72.05. On the upside, there is a resistance level at 74.24. A further resistance level may holdings at 74.85. The Relative Strength Index (RSI) on the 14-day chart is 61.01, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 3.76, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 13.42%. Stochastics %K at 85.19% indicates the stock is a selling.
The most recent change occurred on December 08, 2023 when Wells Fargo began covering the stock and recommended ‘”an Overweight”‘ rating along with a $55 price target.
